| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5053f82a7cd17c60822674b657cfb89e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72 |
| filingDate |
2005-03-14^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32ad655c1c4699081708494ba10385c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c48c5121ccef33d9304e8e82f4cb98df |
| publicationDate |
2006-12-29^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20060135873-A |
| titleOfInvention |
Salmeterol Inhalation Formulations |
| abstract |
The present invention provides a quantitative spray inhalation (MDI) formulation for once-daily administration comprising salmeterol or a physiologically acceptable salt thereof, and a propellant. Dry powder inhalation (DPI) formulations for once-daily administration include salmeterol or its physiologically acceptable salts, and diluents. The invention also provides a unit dose inhalation formulation for once-daily administration comprising 25 to 50 mcg of salmeterol, or a pharmaceutically acceptable salt thereof, ester of another derivative thereof, as an active ingredient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016052897-A1 |
| priorityDate |
2004-03-12^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |